400-920-2911 sales@csnpharm.cn
CAS No.: 1204317-86-1
Synonyms: CAT-1004
Edasalonexent is an orally bioavailable NF-κB inhibitor.
生物活性
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
---|---|---|---|---|---|
NCT02439216 | Muscular Dystrophy, Duchenne | Phase 1 Phase 2 | Active, not recruiting | August 2019 | United States, California ... more >> Los Angeles, California, United States, 90095 United States, Florida Gainesville, Florida, United States, 32610 Orlando, Florida, United States, 32827 United States, Oregon Portland, Oregon, United States, 97239 United States, Pennsylvania Philadelphia, Pennsylvania, United States, 19104 Collapse << |
NCT03703882 | Muscular Dystrophy, Duchenne | Phase 3 | Recruiting | June 2020 | United States, Arkansas ... more >> Arkansas Children's Hospital Recruiting Little Rock, Arkansas, United States, 72202 Contact: Vikki A Stefans, MD Principal Investigator: Vikki A Stefans, MD United States, Georgia Rare Disease Research, LLC Recruiting Atlanta, Georgia, United States, 30318 Contact: Tu Tran, BS Principal Investigator: Han Phan, MD United States, Maryland Kennedy Krieger Institute Recruiting Baltimore, Maryland, United States, 21205 Contact: Genila Bibat, MD Principal Investigator: Katherine R Wagner, MD, PhD United States, Michigan University of Michigan Recruiting Ann Arbor, Michigan, United States, 48109 Contact: Amy Hurst, CCRC Principal Investigator: Erin Neil, DO United States, Oregon Shriners Hospitals for Children Recruiting Portland, Oregon, United States, 97239 Contact: Paige Lemhouse, BS Principal Investigator: Erika Finanger, MD Collapse << |
实验方案
技术信息
CAS号 | 1204317-86-1 | 储存条件 |
|
|
分子式 | C31H42N2O3 | 运输 | 蓝冰 | |
分子量 | 490.68 | 别名 | CAT-1004 |
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
---|
NCT02439216 | Muscular Dystrophy, Duchenne | Phase 1 Phase 2 | Active, not recruiting | August 2019 | United States, California ... more >> Los Angeles, California, United States, 90095 United States, Florida Gainesville, Florida, United States, 32610 Orlando, Florida, United States, 32827 United States, Oregon Portland, Oregon, United States, 97239 United States, Pennsylvania Philadelphia, Pennsylvania, United States, 19104 Collapse << |
NCT03703882 | Muscular Dystrophy, Duchenne | Phase 3 | Recruiting | June 2020 | United States, Arkansas ... more >> Arkansas Children's Hospital Recruiting Little Rock, Arkansas, United States, 72202 Contact: Vikki A Stefans, MD Principal Investigator: Vikki A Stefans, MD United States, Georgia Rare Disease Research, LLC Recruiting Atlanta, Georgia, United States, 30318 Contact: Tu Tran, BS Principal Investigator: Han Phan, MD United States, Maryland Kennedy Krieger Institute Recruiting Baltimore, Maryland, United States, 21205 Contact: Genila Bibat, MD Principal Investigator: Katherine R Wagner, MD, PhD United States, Michigan University of Michigan Recruiting Ann Arbor, Michigan, United States, 48109 Contact: Amy Hurst, CCRC Principal Investigator: Erin Neil, DO United States, Oregon Shriners Hospitals for Children Recruiting Portland, Oregon, United States, 97239 Contact: Paige Lemhouse, BS Principal Investigator: Erika Finanger, MD Collapse << |
联系我们
官方电话:400-920-2911
二维码
微信公众号 CSN官网